News
Biocon eyes weight-loss market in Canada, to file for generic Wegovy, Ozempic’s regulatory approvals
The company is seeking regulatory approval of generic Ozempic by September from Canadian authorities, along with other emerging markets, Bloomberg News reported.
The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...
Biocon Ltd. is set to seek regulatory approvals for generic versions of Novo Nordisk's Ozempic and Wegovy, targeting key ...
Europe’s most expensive stocks aren’t scattered evenly; they’re concentrated in a handful of economic hubs known for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results